Peking University

This trial tests a personalized treatment plan for people with advanced colorectal cancer that has spread to the liver and stopped responding to standard treatments. The approach combines a liver-directed chemotherapy (HAIC), a targeted therapy (fruquintinib or cetuximab), and an…

This study tests whether adding a liver-directed chemotherapy infusion (HAIC) to a standard two-drug combination (lenvatinib and a PD-1 inhibitor) helps people with advanced liver cancer that has invaded major blood vessels or bile ducts. About 150 adults will receive either the …

This phase 2 trial is testing whether adding the targeted drug dalpiciclib to standard hormone therapy (letrozole) before surgery can improve outcomes for women with HR+/HER2- early-stage breast cancer. The study enrolls 100 women aged 18-70 whose tumors have a high genetic risk …

This phase 2 study tests a drug called AK104, which helps the immune system attack cancer cells, in people with specific types of stomach or colorectal cancer. Participants receive the drug before and after surgery to see if it can completely eliminate the tumor. The trial involv…

This phase II trial tests whether adding two targeted drugs (nimotuzumab and camrelizumab) to standard chemotherapy before surgery can improve outcomes for people with locally advanced esophageal cancer. About 48 participants will be randomly assigned to receive the combination o…

This study tests a program that uses kindergartens, families, and hospitals to prevent obesity in children aged 4-6. About 980 children in China will take part. The program includes teacher training, health lessons, parent education, and check-ups. Researchers will measure change…

This study tests a digital health platform delivered through WeChat to prevent obesity in 1,400 school children in grades 2 and 3. The program includes health education, growth monitoring, behavior tracking, and home-school partnerships. Researchers will compare children using th…

This study tests a new AI-powered toolkit designed to help public health officials at local CDC offices respond more quickly to emerging infectious diseases such as COVID-19, mpox, influenza, and dengue. The toolkit combines data analysis, risk assessment, decision support, and e…

This study looks at whether digital health tools like text messages, videos, or AI conversations can improve the physical and mental health of middle school students. About 800 students aged 11 to 13, with normal weight, overweight, or obesity, will be split into four groups to c…

This study looks at whether AI chatbots can improve how much adults know about anxiety and how they feel about it. About 200 people will use either a chatbot or read standard materials for one week. The goal is to see if chatting with AI helps people learn more and feel more conf…

This study looks at what people think about using large language models (a type of AI) in medicine. Researchers will survey 3000 adults to see if providing certain information can change their views. The goal is to understand public acceptance, not to test a treatment.

This study looks at whether a personalized brain-training program can improve memory and thinking in older adults (60+) who have high blood pressure but no dementia. 120 participants will be randomly assigned to either the adaptive training or a placebo version for 12 weeks. The …